These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 31273865
1. Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data. Menghini L, Recinella L, Leone S, Chiavaroli A, Cicala C, Brunetti L, Vladimir-Knežević S, Orlando G, Ferrante C. Phytother Res; 2019 Sep; 33(9):2152-2162. PubMed ID: 31273865 [Abstract] [Full Text] [Related]
3. The Fight against Infection and Pain: Devil's Claw (Harpagophytum procumbens) a Rich Source of Anti-Inflammatory Activity: 2011-2022. Gxaba N, Manganyi MC. Molecules; 2022 Jun 06; 27(11):. PubMed ID: 35684573 [Abstract] [Full Text] [Related]
5. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens. Mncwangi N, Chen W, Vermaak I, Viljoen AM, Gericke N. J Ethnopharmacol; 2012 Oct 11; 143(3):755-71. PubMed ID: 22940241 [Abstract] [Full Text] [Related]
8. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro. Abdelouahab N, Heard C. J Nat Prod; 2008 May 11; 71(5):746-9. PubMed ID: 18412394 [Abstract] [Full Text] [Related]
9. The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil's claw (Harpagophyti radix) preparations. Modarai M, Suter A, Kortenkamp A, Heinrich M. J Pharm Pharmacol; 2011 Mar 11; 63(3):429-38. PubMed ID: 21749392 [Abstract] [Full Text] [Related]
10. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay. Anauate MC, Torres LM, de Mello SB. Phytother Res; 2010 Sep 11; 24(9):1365-9. PubMed ID: 20812280 [Abstract] [Full Text] [Related]
11. Pharmacokinetics of harpagoside in horses after intragastric administration of a Devil's claw (Harpagophytum procumbens) extract. Axmann S, Hummel K, Nöbauer K, Razzazi-Fazeli E, Zitterl-Eglseer K. J Vet Pharmacol Ther; 2019 Jan 11; 42(1):37-44. PubMed ID: 30242850 [Abstract] [Full Text] [Related]
14. Quality Assessment of Commercial Spagyric Tinctures of Harpagophytum procumbens and Their Antioxidant Properties. Avato P, Argentieri MP. Molecules; 2019 Jun 17; 24(12):. PubMed ID: 31212908 [Abstract] [Full Text] [Related]
15. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages. Inaba K, Murata K, Naruto S, Matsuda H. J Nat Med; 2010 Apr 17; 64(2):219-22. PubMed ID: 20177800 [Abstract] [Full Text] [Related]
16. Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats. Joshi K, Parrish A, Grunz-Borgmann EA, Gerkovich M, Folk WR. BMC Complement Med Ther; 2020 Jan 15; 20(1):9. PubMed ID: 32020872 [Abstract] [Full Text] [Related]
20. Devil's Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease. Whitehouse LW, Znamirowska M, Paul CJ. Can Med Assoc J; 1983 Aug 01; 129(3):249-51. PubMed ID: 6407745 [Abstract] [Full Text] [Related] Page: [Next] [New Search]